NOVAREMED LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NOVAREMED LTD..The latest application filed is for "compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity".

Company Profile

2.12.11

NOVAREMED LTD. - Petah Tikva IL
Novaremed Ltd. - Petah Tiqwa IL
Novaremed Limited - Petah Tiqwa IL
NOVAREMED LTD - Tel Aviv IL
Novaremed Limited - IL IL
Novaremed Limited - Tel-Aviv IL
Novaremed Limited - Ramat HaSharon IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For Use In The Treatment Or Prophylaxis Of Pain, Inflammation And/or Autoimmunity App 20220002228 - KAPLAN; Eli ; et al.	2022-01-06
Method Of Treating Or Preventing Pain App 20160317479 - Kaplan; Eliahu	2016-11-03
Isolated stereoisomeric forms of (S)2-N(3-O-(propan 2-Ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide Grant 9,381,173 - Kaplan July 5, 2	2016-07-05
N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation Grant 9,199,917 - Kaplan December 1, 2	2015-12-01
N-substituted benzenepropanamide and benzenepropenamide for use in the prevention or the treatment of affective disorders Grant 9,133,103 - Kaplan , et al. September 15, 2	2015-09-15
N-Substituted Benzenepropanamide or Benzenepropenamide Derivatives for use in the Treatment of Pain and Inflammation App 20150080473 - Kaplan; Eliahu	2015-03-19
Method of Treating or Preventing Pain App 20140350099 - Kaplan; Eliahu	2014-11-27
N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation Grant 8,883,853 - Kaplan November 11, 2	2014-11-11
N-Substituted Benzenepropanamide and Benzenepropenamide For Use in the Prevention or the Treatment of Affective Disorders App 20140275273 - Kaplan; Eliahu ; et al.	2014-09-18
Isolated Stereoisomeric Forms Of (S)2-N(3-O-(Propan 2-Ol)-1-Propyl-4-Hydroxybenzene)-3-Phenylpropylamide App 20140275270 - Kaplan; Eliahu	2014-09-18
Method of treating or preventing pain Grant 8,802,734 - Kaplan August 12, 2	2014-08-12
Treatment Of Cell Proliferative Disorders App 20140039060 - Kaplan; Eliahu	2014-02-06
Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection Grant 8,309,606 - Kaplan November 13, 2	2012-11-13
Compounds for the treatment of AIDS and other viral diseases Grant 8,252,843 - Kaplan August 28, 2	2012-08-28
Method Of Treating Or Preventing Pain App 20110086910 - Kaplan; Eliahu	2011-04-14
Compounds For The Treatment Of Aids And Other Viral Diseases App 20100331383 - Kaplan; Eliahu	2010-12-30
Compounds for the treatment of AIDS and other viral diseases Grant 7,754,771 - Kaplan July 13, 2	2010-07-13
Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection App 20100069454 - Kaplan; Eliahu	2010-03-18
Compounds for the treatment of AIDS and other viral diseases Grant 7,674,829 - Kaplan March 9, 2	2010-03-09
Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection Grant 7,642,290 - Kaplan January 5, 2	2010-01-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.